Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Arena Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/364,425external-prioritypatent/US6653086B1/en
Application filed by IndividualfiledCriticalIndividual
Priority claimed from PCT/US2000/004945external-prioritypatent/WO2001062765A2/fr
Publication of CA2368447A1publicationCriticalpatent/CA2368447A1/fr
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
L'invention concerne des modulateurs à petites molécules du récepteur six couplé à la protéine G, des procédés de fabrication de tels composés et des méthodes d'utilisation de ces composés.
CA002368447A1999-02-262000-02-25Modulateurs a petites molecules du recepteur six couple a la proteine g
AbandonedCA2368447A1
(fr)
Compositions pour traiter des bouffees congestives et des troubles d'ordre lipidique, ces compositions contenant des agonistes partiels du recepteur de la niacine
Derives d'acide 2h-pyrazol-3- carboxylique substitues en 5 utilises comme agonistes du recepteur de l'acide nicotinique rup25 pour le traitement des dyslipidemies et des pathologies apparentees